Bile Acid Diarrhea in Crohn's: Causes and Treatment

This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before making any changes to your treatment plan.
If your diarrhea keeps coming back even though your Crohn's disease looks calm on scans and bloodwork, you are not imagining things. Bile acid diarrhea in Crohn's disease is one of the most common yet overlooked reasons for persistent watery stools - affecting more than 30% of patients with Crohn's (1). The good news is that once recognized, it is usually very treatable.
Key Takeaways
- More than 30% of Crohn's disease cases are complicated by bile acid malabsorption, often missed because symptoms mimic a flare (1)
- After ileocaecal resection, up to 90% of patients may have severe bile acid malabsorption on SeHCAT testing (2)
- The SeHCAT scan is the gold-standard diagnostic test, with 96% sensitivity and 100% specificity, but availability varies by country (4)
- First-line treatment is a bile acid sequestrant such as cholestyramine, colestipol, or colesevelam, often combined with a low-fat diet (6)
- A 2025 study found that IBD patients with bile acid malabsorption had a 66.67% clinical response rate after fecal microbiota transplantation, compared to 49.41% in non-BAM patients (1)

What Is Bile Acid Diarrhea?
Bile acid diarrhea - sometimes called bile acid malabsorption, or BAM - happens when bile acids that should be recycled in your small intestine instead spill into the colon, where they trigger watery stools, urgency, and cramping. The condition affects roughly 1% of the general Western population, but the rate is dramatically higher in people with Crohn's disease (5).
How bile acids normally work
Your liver produces bile acids and releases them into the small intestine after meals to help digest fats. The terminal ileum - the last section of the small intestine - normally reabsorbs about 95% of those bile acids and returns them to the liver. This recycling loop, called the enterohepatic circulation, means almost no bile acid reaches the colon under healthy conditions.
What happens when reabsorption fails
When the terminal ileum is inflamed, scarred, or surgically removed, it can no longer recapture bile acids efficiently. The excess passes into the colon, stimulating water secretion, speeding up transit, and causing watery, urgent diarrhea. This is the same part of the intestine that absorbs vitamin B12 - which is why bile acid problems and B12 deficiency so often travel together in Crohn's patients.
Three types of bile acid diarrhea
Researchers classify BAD into three types (5). Type 1 results from ileal disease or surgical resection - the type most directly relevant to Crohn's. Type 2 is primary or idiopathic, meaning no structural cause is found; this form likely accounts for many cases currently mislabeled as diarrhea-predominant IBS. Type 3 is secondary to other gastrointestinal conditions such as celiac disease, small intestinal bacterial overgrowth, or radiation enteritis.
Why Crohn's Disease Patients Are at High Risk
Crohn's has a particular affinity for the terminal ileum - the exact stretch of bowel responsible for bile acid reabsorption. That overlap makes bile acid diarrhea one of the most predictable yet under-recognized complications in our community.
Ileal disease and inflammation
Patients with Crohn's ileitis are at especially high risk because active inflammation directly impairs the transporters that recapture bile acids. Even patients in clinical remission can have persistent bile acid malabsorption, because mucosal damage may not fully reverse even when inflammation quiets down.
After ileocolonic resection
The risk rises sharply after surgery involving the ileum. One study found that 90% of patients who had undergone ileocaecal resection had abnormal SeHCAT retention below 5%, indicating severe bile acid malabsorption (2). For patients navigating life after resection - something we covered in our postoperative recurrence prevention guide - this is a treatable layer of symptoms that deserves its own workup.
How resection length matters
Resection length shapes treatment strategy. Patients with shorter resections (under 1 meter) typically respond well to bile acid sequestrants alone, while those with longer resections may need additional strategies (3).
Recognizing Symptoms: Is It a Flare or Bile Acid Diarrhea?
Bile acid diarrhea mimics an active Crohn's flare so closely that many patients and clinicians default to the flare explanation without considering BAD. Learning the differences can save months of unnecessary investigation.
Classic symptoms of BAD
The hallmark symptoms include watery diarrhea (often explosive), urgency, nocturnal bowel movements, abdominal cramps, excessive gas, and sometimes fecal incontinence (4). Symptoms tend to worsen after fatty meals because dietary fat triggers extra bile acid release.
Why it gets missed
When a Crohn's patient reports ongoing diarrhea, the first assumption is usually active inflammation, post-surgical changes, or IBS. Up to 30% of patients diagnosed with diarrhea-predominant IBS may actually have undiagnosed bile acid diarrhea (4) - a treatable condition under the wrong label.
Clues that point to BAD
Watch for pale yellow or greenish stools, diarrhea that clearly worsens after high-fat meals, nighttime urgency, and symptoms that persist even when inflammatory markers (CRP, fecal calprotectin) and imaging look normal. If your Crohn's appears controlled on paper but your gut tells a different story, bile acid diarrhea deserves a place in the conversation (4).

Getting Diagnosed: Tests Your Doctor May Use
The diagnostic path depends partly on where you live and what tests your healthcare system offers. Here are the main options.
The SeHCAT scan
The 75SeHCAT test is the gold standard, with 96% sensitivity and 100% specificity (4). You swallow a capsule of radiolabeled synthetic bile acid and have two scans a week apart to measure retention. Results: 10-15% retention indicates mild BAM, 5-10% moderate, and below 5% severe malabsorption (5).
Serum C4 blood test
SeHCAT is widely available in Europe but has limited availability in the United States. The alternative is serum C4 (7-alpha-hydroxy-4-cholesten-3-one) - a blood marker that rises when the liver is overproducing bile acids to compensate for poor recycling. Less precise than SeHCAT, but accessible at most hospital laboratories.
Fecal bile acids and the therapeutic trial
FGF19 levels and direct fecal bile acid measurements remain mostly research tools. In practice, many clinicians use a supervised therapeutic trial of a bile acid sequestrant - patients with BAD typically improve within days to two weeks, making this both a diagnostic and treatment step.
Treatment Options That Actually Help
Effective treatments exist, are widely accessible, and work relatively quickly - many people notice a difference within the first week.
Bile acid sequestrants (cholestyramine, colestipol, colesevelam)
First-line treatment is a bile acid sequestrant - a medication that binds bile acids in the gut so they cannot irritate the colon (6). Cholestyramine and colestipol are powders mixed into water or juice. Colesevelam is a tablet and is often better tolerated.
Practical dosing tips: take sequestrants in divided doses before meals, and separate them from other medications by at least 2-4 hours because they can reduce absorption of other drugs and fat-soluble vitamins.
Dietary approaches
A low-fat diet can improve urgency, bloating, bowel frequency, abdominal pain, and nighttime defecation (4). This does not mean eliminating all fat, but reducing concentrated fat loads (fried foods, rich sauces, heavy dairy) can meaningfully calm symptoms. Loperamide may also provide symptomatic relief under medical guidance, though it does not address the underlying bile acid problem.
Emerging options: FXR agonists and microbiota-based therapy
Researchers are exploring FXR agonists (such as obeticholic acid) that stimulate FGF19 production and reduce bile acid synthesis at its source. These are not yet standard for BAD but represent a promising future direction.
A 2025 BMC Medicine cohort study found that IBD patients with BAM had a clinical response rate of 66.67% after fecal microbiota transplantation, compared to 49.41% in non-BAM patients, with remission rates of 52.38% versus 40.00% (1). This early evidence suggests the gut microbiome plays a direct role in bile acid metabolism.
Living Well With BAD: Practical Daily Tips
Once bile acid diarrhea is diagnosed and treatment begins, most people see real improvement. But daily management involves more than medication alone.
Monitoring fat-soluble vitamins
Chronic BAM can lead to deficiencies in fat-soluble vitamins (A, D, E, K) and calcium, because unabsorbed bile acids mean unabsorbed dietary fat. Ask your gastroenterologist about periodic monitoring, especially after ileal resection. We covered this in our micronutrient deficiencies guide.
Working with your care team
A symptom-food-medication diary kept for several weeks helps your team distinguish BAD from active inflammation, dietary triggers, and medication side effects. Note fat content of meals, symptom timing, and sequestrant dosing.
For travel and work, many people with BAD plan around bathroom access. Discreet tools like bathroom-access cards and mapping restroom locations can reduce anxiety.
When to seek further evaluation
Push for a bile acid workup if diarrhea persists despite controlled inflammation, after any ileal resection, or if symptoms worsen after high-fat meals. If unpredictable bowel habits are affecting your mental health, bowel-directed hypnotherapy and cognitive behavioral therapy can both help.
Frequently Asked Questions
Is bile acid diarrhea the same as a Crohn's disease flare?
No. BAD is caused by poor reabsorption of bile acids, not active inflammation. The symptoms overlap - watery diarrhea, urgency, cramping - but BAD can persist even when markers and imaging show controlled Crohn's. The distinction matters because treatments are different.
How do I know if I have bile acid diarrhea or IBS?
Up to 30% of people diagnosed with diarrhea-predominant IBS may actually have undiagnosed BAD (4). Clues include symptoms that worsen after fatty meals, pale or greenish stools, and nighttime urgency. A SeHCAT scan, C4 blood test, or supervised trial of a bile acid sequestrant can clarify the diagnosis.
What is the SeHCAT test and is it available everywhere?
SeHCAT is a nuclear medicine scan measuring bile acid retention over seven days, with 96% sensitivity and 100% specificity (4). It is widely available in Europe but has limited access in the United States. Where unavailable, serum C4 testing or a therapeutic trial of a sequestrant are common alternatives.
Can bile acid diarrhea be cured, or is it lifelong?
It depends on the cause. If BAD stems from active ileal inflammation, treating the Crohn's may improve bile acid absorption. If the ileum has been removed or permanently scarred, sequestrant therapy is typically ongoing - but most patients find symptoms become very manageable with the right dose and dietary adjustments.
Do bile acid sequestrants interact with my other Crohn's medications?
Yes. Sequestrants can reduce absorption of other medications taken at the same time, so the standard advice is to separate them by at least 2-4 hours (6). They can also reduce fat-soluble vitamin absorption, making periodic monitoring important.
Should I follow a low-fat diet if I have BAD?
Moderating concentrated fat loads (fried foods, cream-based dishes) can reduce urgency, bloating, and nighttime bowel movements (4). The goal is not to eliminate fat entirely but to avoid large, concentrated doses. A registered dietitian can help tailor a sustainable plan.
What should I ask my doctor about bile acid diarrhea?
Key questions: "Could my diarrhea be bile acid malabsorption rather than active Crohn's?", "Would a SeHCAT or C4 test be appropriate?", "Could we try a bile acid sequestrant?", and "Should I be monitoring fat-soluble vitamins?" These help ensure BAD is not overlooked.
References
- Lu, Y., et al. Fecal microbiota transplantation improves bile acid malabsorption in patients with inflammatory bowel disease: results of microbiota and metabolites from two cohort studies. BMC Medicine, 2025. View on PubMed
- Vitek, L. Bile Acid Malabsorption in Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 2015. Read study
- Wu, Y., et al. Postoperative diarrhea in Crohn's disease: Pathogenesis, diagnosis, and therapy. World Journal of Gastrointestinal Surgery, 2023. Read study
- Farrugia, A., Arasaradnam, R. Bile acid diarrhoea: pathophysiology, diagnosis and management. Frontline Gastroenterology, 2020. Read study
- Camilleri, M. Bile Acid Diarrhea: Prevalence, Pathogenesis, and Therapy. Gut and Liver, 2015. Read study
- Cleveland Clinic. Bile Acid Malabsorption: Symptoms, Causes and Treatment. 2024. Read article
- IBD Relief. Bile Acid Malabsorption (BAM). 2024. Read article
Recommended Resources
Browse ResourcesRelated Articles

Endoscopic Balloon Dilation for Crohn's Strictures Guide
Endoscopic balloon dilation for Crohn's strictures offers a minimally invasive alternative to surgery. Learn success rates, risks, and patient outcomes.

Vaccines for Crohn's Disease: What Patients Need to Know
Vaccines for Crohn's disease patients matter most before you start biologics. Learn which shots are safe, which ones to avoid, and how to time them right.

Preventing Postoperative Crohn's Recurrence: 2026 Guide
Up to half of Crohn's patients face endoscopic recurrence within a year of surgery. Learn 2026 evidence-based ways to prevent postoperative recurrence.

Capsule Endoscopy for Crohn's Disease: A Patient Guide
Capsule endoscopy for Crohn's disease uses a tiny swallowable camera to image the entire small bowel. Learn how PillCam works, what to expect, and the risks.

MR Enterography for Crohn's Disease: A Patient's Guide
MR enterography for Crohn's disease is a radiation-free scan that maps small bowel inflammation. Learn how MRE works, what to expect, and why it matters.

Top-Down vs Step-Up Therapy for Crohn's: PROFILE Trial
PROFILE trial shows top-down therapy for Crohn's disease beats step-up: 79% sustained remission vs 15% at one year. What newly diagnosed patients need to know.